$0.074
-0.027 (-37.11%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BTAI Prediction & Forecast by Similar Chart Analysis
Alphio's BTAI stock price prediction model matches the current BioXcel Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.07 (-0.11%). The 1-week path is $0.07 (+0.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BioXcel Therapeutics Inc Stock?
BioXcel Therapeutics Inc is not a good buy right now due to its significant financial distress and recent bankruptcy filing. The current price is $0.0739, which reflects a staggering 95.65% decline year-to-date. Additionally, the company has reported a gross margin of only 87.91% in the most recent quarter, indicating severe operational challenges. The primary risk is its recent bankruptcy filing, which raises concerns about the company's ability to continue operations and meet obligations.
BTAI stock price ended at $0.07 on Friday, after losing -37.11%
BioXcel Therapeutics Inc (BTAI) last closed at $0.0739, losing -37.11%. These facts feed the 1-day and 1-week BTAI price prediction above.
Analyst Consensus
BioXcel Therapeutics Inc (BTAI): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
BioXcel Therapeutics Inc (BTAI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BTAI, ranked by similarity.
Seasonality analysis for BTAI
Historically the probability of a positive November return for BTAI is 0.00%. January offers the highest probability of a positive month at 39.34%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BTAI
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.92 | $0.94 | $0.95 | +1166.93% |
| Dec 2026 | $0.70 | $0.86 | $0.94 | +1064.31% |
In 2026, BioXcel Therapeutics Inc (BTAI) is projected to range from $0.70 to $0.95.
BioXcel Therapeutics Inc 2026 monthly forecast
In Nov 2026, BioXcel Therapeutics Inc is projected to average $0.94, with a low of $0.92 and high of $0.95.
In Dec 2026, BioXcel Therapeutics Inc is projected to average $0.86, with a low of $0.70 and high of $0.94.
Related articles
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.